LETI’s research will help apply magnetotactic bacteria in oncology
Kamil Gareev, Associate Professor at ETU "LETI," justified the prospects of using magnetotactic bacteria to treat malignant tumors.Credit: Saint Petersburg ...
Kamil Gareev, Associate Professor at ETU "LETI," justified the prospects of using magnetotactic bacteria to treat malignant tumors.Credit: Saint Petersburg ...
Credit: Mary Ann Liebert, Inc., publishers New Rochelle, NY, July 13, 2021--Males with COVID-19 had significantly higher rates of hospitalization ...
The Environmental Determinants of Diabetes in the Young study is led by USF Health's Jeffrey Krischer, who has built a ...
Treatment with VivAer, a non-invasive, temperature-controlled, radiofrequency (RF) device, resulted in significant symptom relief, superior to sham controlCredit: (C) Aerin ...
SK Chemicals-Standigm will collaborate for the development of Standigm's AI-driven drug candidateCredit: Standigm Standigm Inc. ("Standigm"), a leading workflow artificial ...
The Brigham-Wyss diagnostic accelerator aims to create new diagnostic technologies through deep collaborations driven by unmet diagnostic needsCredit: Wyss Institute ...
Clinical studies of COVID-19 drugs may benefit from randomization and early recruitment, model showsCredit: (c) Tomoki Shimizu / Kyoto University ...
A 27-question survey of Association of American Cancer Institutes (AACI) members, including many NCI-designated centers, identified several opportunities to improve ...
A new study shows how a change in diet based on certain classes of fatty acids decreased headaches in patients ...
Existing medications can reduce severity by 'at least 30%'Credit: The Hospital Research Foundation, South Australia In an Australian world-first, researchers ...
A pair of clinical trials at UC San Diego Health and Altman Clinical and Translational Research Institute seek to quantify ...
Study: Plastic better than cloth for low birth-weight newbornsCredit: University of Houston Most babies born prematurely or with health problems ...
Phase 1 trials conducted at NIH Clinical CenterCredit: NIAID WHAT: Two U.S. Phase 1 clinical trials of a novel candidate ...
Credit: Mary Ann Liebert, Inc., publishers Among low-income, uninsured, or publicly insured women ages 25-64 years who were not up ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.
© 2019 Bioengineer.org - Biotechnology news by Science Magazine - Scienmag.